These stocks are offering the yield of dreams. But are their rich dividend payouts secure?» Read More
CNBC's Bertha Coombs covers the Nasdaq movers on the day, including big tech names countering the Netflix selloff.
CNBC's Bob Pisani tracks the most important market movers, including a resurgence of stability in emerging markets.
Angel investor and Collective[i] founder Heidi Messer discusses how tech can address its diversity problem.
Joey Levy, CEO of sports gambling site Draft Pot, debates the need for regulation with sports attorney Darren Heitner.
Bank repossessions soared 66 percent in the third quarter and it could have a ripple effect in housing, reports CNBC's Diana Olick.
The FBI is investigating inside bets made by employees at daily fantasy sports sites, reports CNBC's Eamon Javers.
Shares of Valeant Pharmaceuticals plunged after the drug maker was subpoenaed over pricing. CNBC's Meg Tirrell covers what it means for big pharma.
Steve Jordan’s office is 400 feet above the ground. As a banner tow pilot, Jordan flies advertisements along the beaches of New Jersey
CNBC's Bob Pisani covers the First Data IPO, the largest of the year, and what its performance means for the broader market.
China sold millions in US Treasurys in a few months. Does this spell doom for the US economy?
What's contributing to market volatility?
US oil closed down 0.6 percent as the government reported a larger-than-expected crude stockpile build.
More than 123,000 homes went back to the bank in the third quarter, as banks have finally reached a point where they can push foreclosures forward.
Wal-Mart's guidance surprise is only bad news for investors taking a short-term view, Moody's Charles O'Shea said.
Bank earnings expectations aren't great, but traders say the real problem lies elsewhere.
One industry expert says fully autonomous models could hit the market as early as 2020.
Pats QB: Frosted Flakes not so grrrrreat
Jay Kaplan, & Co-Porfolio Manager of the Royce Total Return Fund, Co-Portfolio Manager of the Royce Dividend Value Fund, discusses the Russell 2,000, where he's found some small cap value picks with big returns.
"Power Lunch" hosts Melissa Lee and Brian Sullivan look at 5 stocks with analyst recommendations, including Oracle and Dollar General.
CNBC's Meg Tirrell reports that Turing Pharmaceuticals CEO Martin Shkreli has not kept his promise to lower the price of Daraprim.